Article Information
History
- November 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Leticia Leon1,2,*,
- Alfredo Madrid-García1,
- Patricia Lopez-Viejo3,
- Isidoro González-Álvaro4,
- Marta Novella-Navarro,
- Dalifer Freites Nuñez3,
- Zulema Rosales3,
- Benjamin Fernandez-Gutierrez3 and
- Lydia Abasolo1
- 1Instituto de Investigacion Sanitaria San Carlos (IdISSC). Rheumatology Department. Hospital Clínico San Carlos. Madrid, Spain
- 2Health Sciences, Universidad Camilo Jose Cela. Madrid,Spain
- 3Rheumatology Department. Hospital Clínico San Carlos. Madrid, Spain
- 4Rheumatology Department. Hospital Universitario La Princesa. Madrid, Spain 5. Rheumatology Department. Hospital Universitario La Paz. Madrid, Spain
- ↵*Corresponding author: Dr Leticia Leon
, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Hospital Clínico San Carlos; Madrid, Spain. Calle Martín Lagos, s/n. 28040 Madrid – Spain, e-mail: lleon.hcsc{at}salud.madrid.org Tel/Fax.: +34 – 913303615/3414
Posted November 05, 2022.
Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos